We have located links that may give you full text access.
Rebound hyperbilirubinemia in term infants after phototherapy.
Saudi Medical Journal 2002 November
OBJECTIVE: To determine whether a rebound in serum bilirubin level occurs within 24 hours after discontinuation of phototherapy in term infants with hyperbilirubinemia.
METHODS: A retrospective medical record review of term infants with hyperbilirubinemia requiring phototherapy who were admitted over 24 months, June 1999 to December 2001, at King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia was completed. Total serum bilirubin levels (TSB) at and up to 24 hours after termination of phototherapy (follow-up levels) were recorded. The difference between mean TSB level at termination of phototherapy and at follow-up was calculated using the paired t test.
RESULTS: Three hundred and one infants, 53% (n=161) were boys, mean standard deviation (SD) for gestational age was 39.4 +/- 1.4 weeks, mean birth weight was 3200 +/- 600 g, mean TSB SD at termination of phototherapy was 193 +/- 46 micromole/liter (micromol/l) and at follow-up was 188 +/- 45 micromol/l for all infants with either positive or negative direct coombs' test results. The difference in mean TSB level at discontinuation of phototherapy and at follow-up was statistically significant, (t=3.12, P=0.002). The mean TSB level at termination of phototherapy was 179 +/- 47 micromol/l and at follow-up was 177 +/- 47 micromol/l for 65 infants with positive direct coombs' test results. This difference was statistically insignificant (t=0.725, P=0.47). The mean time interval between the termination of phototherapy and the measurement of follow-up TSB level was 8.3 +/- 5.3 hour.
CONCLUSION: The rebound of bilirubin level after termination of phototherapy in otherwise healthy term infants is minimal; thus measurement of serum bilirubin is not required after termination of phototherapy and adds unnecessary expense, prolongs hospitalization, or both.
METHODS: A retrospective medical record review of term infants with hyperbilirubinemia requiring phototherapy who were admitted over 24 months, June 1999 to December 2001, at King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia was completed. Total serum bilirubin levels (TSB) at and up to 24 hours after termination of phototherapy (follow-up levels) were recorded. The difference between mean TSB level at termination of phototherapy and at follow-up was calculated using the paired t test.
RESULTS: Three hundred and one infants, 53% (n=161) were boys, mean standard deviation (SD) for gestational age was 39.4 +/- 1.4 weeks, mean birth weight was 3200 +/- 600 g, mean TSB SD at termination of phototherapy was 193 +/- 46 micromole/liter (micromol/l) and at follow-up was 188 +/- 45 micromol/l for all infants with either positive or negative direct coombs' test results. The difference in mean TSB level at discontinuation of phototherapy and at follow-up was statistically significant, (t=3.12, P=0.002). The mean TSB level at termination of phototherapy was 179 +/- 47 micromol/l and at follow-up was 177 +/- 47 micromol/l for 65 infants with positive direct coombs' test results. This difference was statistically insignificant (t=0.725, P=0.47). The mean time interval between the termination of phototherapy and the measurement of follow-up TSB level was 8.3 +/- 5.3 hour.
CONCLUSION: The rebound of bilirubin level after termination of phototherapy in otherwise healthy term infants is minimal; thus measurement of serum bilirubin is not required after termination of phototherapy and adds unnecessary expense, prolongs hospitalization, or both.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app